Keywords: data, aapsnb, validates, nastech, intranasal, platform, usa

Data at the AAPSNB validates Nastech's intranasal platform

Article | 03 July 2006

Print This

The USA's Nastech Pharmaceutical says that in vitro and in vivo findings with its proprietary intranasal formulation of GLP-1 indicate ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in